Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping

Journal of Experimental and Clinical Cancer Research

Volumn 32, Issue 1, 2013, Pages

  Kim, Hye Ryoun ^a   Lee, Sung Yong ^b   Hyun, Dae Sung ^c   Lee, Min Ki ^d   Lee, Hyun Kyung ^e   Choi, Chang Min ^f   Yang, Sei Hoon ^g   Kim, Young Chul ^h   Lee, Yong Chul ⁱ   Kim, Sun Young ^j   Jang, Seung Hun ^k   Lee, Jae Cheol ^f   Lee, Kye Young ^l  

^a Korea Cancer Center Hospital   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Catholic University of Daegu   (South Korea)

^d Pusan National University Hospital   (South Korea)

^e Inje University College of Medicine   (South Korea)

^f University of Ulsan College of Medicine   (South Korea)

^g Wonkwang University Hospital   (South Korea)

^h Chonnam National University   (South Korea)

ⁱ Chonbuk National University Medical School   (South Korea)

^j Chungnam National University College of Medicine   (South Korea)

^k Hallym University   (South Korea)

^l Konkuk University Hospital   (South Korea)

more..

Author keywords

EGFR mutation; Non small cell lung cancer; Plasma; PNA mediated PCR clamping method

Indexed keywords

CIRCULATING FREE DNA; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; PEPTIDE NUCLEIC ACID; UNCLASSIFIED DRUG; EGFR PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER TISSUE; CONTROLLED STUDY; DNA SEQUENCE; EXON; FEMALE; GENE DELETION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POINT MUTATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SMOKING; TREATMENT RESPONSE; BLOOD; CLINICAL TRIAL; ENZYMOLOGY; GENETICS; LUNG TUMOR; MIDDLE AGED; MULTICENTER STUDY; MUTATION; NON SMALL CELL LUNG CANCER; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84881137132     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-32-50     Document Type: Article

References (35)

1. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. Mok TS, Wu YL, Thongprasert S, Yang CH, Chu DT, Saijo N, Sunpaweravong P, Han B, Margono B, Ichinose Y, Nishiwaki Y, Ohe Y, Yang JJ, Chewaskulyong B, Jiang H, Duffield EL, Watkins CL, Armour AA, Fukuoka M, N Engl J Med 2009 361 947 957 10.1056/NEJMoa0810699 19692680
2. European EGFR Workshop Group. Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop. Pirker R, Herth FJ, Kerr KM, Filipits M, Taron M, Gandara D, Hirsch FR, Grunenwald D, Popper H, Smit E, Dietel M, Marchetti A, Manegold C, Schirmacher P, Thomas M, Rosell R, Cappuzzo F, Stahel R, J Thorac Oncol 2010 5 1706 1713 10.1097/JTO. 0b013e3181f1c8de 20871269
3. EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. Marchetti A, Martella C, Felicioni L, Barassi F, Salvatore S, Chella A, Camplese PP, Iarussi T, Mucilli F, Mezzetti A, Cuccurullo F, Sacco R, Buttitta F, J Clin Oncol 2005 23 857 865 10.1200/JCO.2005.08.043 15681531
4. Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay. Endo K, Konishi A, Sasaki H, Takada M, Tanaka H, Okumura M, Kawahara M, Sugiura H, Kuwabara Y, Fukai I, Matsumura A, Yano M, Kobayashi Y, Mizuno K, Haneda H, Suzuki E, Iuchi K, Fujii Y, Lung Cancer 2005 50 375 384 10.1016/j.lungcan.2005.08.009 16199108
5. Rapid detection of epidermal growth factor receptor mutations in non-small cell lung cancer using real-time polymerase chain reaction with TaqMan-MGB probes. Zhou C, Ni J, Zhao Y, Su B, Cancer J 2006 12 33 39 10.1097/00130404-200601000-00007 16613660
6. A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer. Yatabe Y, Hida T, Horio Y, Kosaka T, Takahashi T, Mitsudomi T, J Mol Diagn 2006 8 335 341 10.2353/jmoldx.2006.050104 16825506
7. Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas. Pan Q, Pao W, Ladanyi M, J Mol Diagn 2005 7 396 403 10.1016/S1525-1578(10)60569-7 16049312
8. Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers. Tanaka T, Nagai Y, Miyazawa H, Koyama N, Matsuoka S, Sutani A, Huqun, Udagawa K, Murayama Y, Nagata M, Shimizu Y, Ikebuchi K, Kanazawa M, Kobayashi K, Hagiwara K, Cancer Sci 2007 98 246 252 10.1111/j.1349-7006.2006.00377.x 17233841
9. A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening. Janne PA, Borras AM, Kuang Y, Rogers AM, Joshi VA, Liyanage H, Lindeman N, Lee JC, Halmos B, Maher EA, Distel RJ, Meyerson M, Johnson BE, Clin Cancer Res 2006 12 751 758 10.1158/1078-0432.CCR-05-2047 16467085
10. Detection of epidermal growth factor receptor variations by partially denaturing HPLC. Chin TM, Anuar D, Soo R, Salto-Tellez M, Li WQ, Ahmad B, Lee SC, Goh BC, Kawakami K, Segal A, Iacopetta B, Soong R, Clin Chem 2007 53 62 70 17110474
11. Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancer. Cohen V, Agulnik JS, Jarry J, Batist G, Small D, Kreisman H, Tejada NA, Miller WH Jr, Chong G, Cancer 2006 107 2858 2865 10.1002/cncr.22331 17096434
12. Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing. Thomas RK, Nickerson E, Simons JF, Janne PA, Tengs T, Yuza Y, Garraway LA, LaFramboise T, Lee JC, Shah K, O'Neill K, Sasaki H, Lindeman N, Wong KK, Borras AM, Gutmann EJ, Dragnev KH, DeBiasi R, Chen TH, Glatt KA, Greulich H, Desany B, Lubeski CK, Brockman W, Alvarez P, Hutchison SK, Leamon JH, Ronan MT, Turenchalk GS, Egholm M, Sellers WR, Rothberg JM, Meyerson M, Nat Med 2006 12 852 855 10.1038/nm1437 16799556
13. Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay. Asano H, Toyooka S, Tokumo M, Ichimura K, Aoe K, Ito S, Tsukuda K, Ouchida M, Aoe M, Katayama H, Hiraki A, Sugi K, Kiura K, Date H, Shimizu N, Clin Cancer Res 2006 12 43 48 10.1158/1078-0432.CCR-05-0934 16397022
14. Rapid detection of epidermal growth factor receptor mutations in lung cancer by the SMart-Amplification Process. Hoshi K, Takakura H, Mitani Y, Tatsumi K, Momiyama N, Ichikawa Y, Togo S, Miyagi T, Kawai Y, Kogo Y, Kikuchi T, Kato C, Arakawa T, Uno S, Cizdziel PE, Lezhava A, Ogawa N, Hayashizaki Y, Shimada H, Clin Cancer Res 2007 13 4974 4983 10.1158/1078-0432.CCR-07-0509 17785547
15. Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method. Pao W, Ladanyi M, Clin Cancer Res 2007 13 4954 4955 10.1158/1078-0432.CCR-07-1387 17785543
16. Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer. Kimura H, Kasahara K, Kawaishi M, Kunitoh H, Tamura T, Holloway B, Nishio K, Clin Cancer Res 2006 12 3915 3921 10.1158/1078-0432.CCR-05-2324 16818687
17. Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp. Nagai Y, Miyazawa H, Huqun, Tanaka T, Udagawa K, Kato M, Fukuyama S, Yokote A, Kobayashi K, Kanazawa M, Hagiwara K, Cancer Res 2005 65 7276 7282 10.1158/0008-5472.CAN-05-0331 16105816
18. Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors. John T, Liu G, Tsao MS, Oncogene 2009 28 Suppl 1 14 S23 19680292
19. The origin and mechanism of circulating DNA. Stroun M, Maurice P, Vasioukhin V, Lyautey J, Lederrey C, Lefort F, Rossier A, Chen XQ, Anker P, Ann N Y Acad Sci 2000 906 161 168 10818614
20. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P, Clin Chim Acta 2001 313 139 142 10.1016/S0009-8981(01)00665-9 11694251
21. Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours. Aung KL, Board RE, Ellison G, Donald E, Ward T, Clack G, Ranson M, Hughes A, Newman W, Dive C, Hugo J 2010 4 11 21 10.1007/s11568-011-9149-2 22132062
22. EGFR mutation of tumor and serum in gefitinib-treated patients with chemotherapy-naive non-small cell lung cancer. Kimura H, Kasahara K, Shibata K, Sone T, Yoshimoto A, Kita T, Ichikawa Y, Waseda Y, Watanabe K, Shiarasaki H, Ishiura Y, Mizuguchi M, Nakatsumi Y, Kashii T, Kobayashi M, Kunitoh H, Tamura T, Nishio K, Fujimura M, Nakao S, J Thorac Oncol 2006 1 260 267 17409866
23. Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA). Kimura H, Suminoe M, Kasahara K, Sone T, Araya T, Tamori S, Koizumi F, Nishio K, Miyamoto K, Fujimura M, Nakao S, Br J Cancer 2007 97 778 784 10.1038/sj.bjc.6603949 17848912
24. Detection of mutations in EGFR in circulating lung-cancer cells. Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, Collura CV, Inserra E, Diederichs S, Iafrate AJ, Bell DW, Digumarthy S, Muzikansky A, Irimia D, Settleman J, Tompkins RG, Lynch TJ, Toner M, Haber DA, N Engl J Med 2008 359 366 377 10.1056/NEJMoa0800668 18596266
25. Noninvasive detection of EGFR T790M in gefitinib or erlotinib resistant non-small cell lung cancer. Kuang Y, Rogers A, Yeap BY, Wang L, Makrigiorgos M, Vetrand K, Thiede S, Distel RJ, Jänne PA, Clin Cancer Res 2009 15 2630 2636 10.1158/1078-0432.CCR-08-2592 19351754
26. EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancer. Mack PC, Holland WS, Burich RA, Sangha R, Solis LJ, Li Y, Beckett LA, Lara PN Jr, Davies AM, Gandara DR, J Thorac Oncol 2009 4 1466 1472 10.1097/JTO.0b013e3181bbf239 19884861
27. Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer. Jian G, Songwen Z, Ling Z, Qinfang D, Jie Z, Liang T, Caicun Z, J Cancer Res Clin Oncol 2010 136 1341 1347 10.1007/s00432-010-0785-z 20155428
28. Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer. Bai H, Mao L, Wang HS, Zhao J, Yang L, An TT, Wang X, Duan CJ, Wu NM, Guo ZQ, Liu YX, Liu HN, Wang YY, Wang J, J Clin Oncol 2009 27 2653 2659 10.1200/JCO.2008.17.3930 19414683
29. Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer. He C, Liu M, Zhou C, Zhang J, Ouyang M, Zhong N, Xu J, Int J Cancer 2009 125 2393 2399 10.1002/ijc.24653 19530244
30. Serum detection of epidermal growth factor receptor gene mutations using mutant-enriched sequencing in Chinese patients with advanced non-small cell lung cancer. Jiang B, Liu F, Yang L, Zhang W, Yuan H, Wang J, Huang G, J Int Med Res 2011 39 1392 1401 10.1177/147323001103900425 21986139
31. Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors. Brevet M, Johnson ML, Azzoli CG, Ladanyi M, Lung Cancer 2011 73 96 102 10.1016/j.lungcan.2010.10.014 21130517
32. Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas. Taniguchi K, Uchida J, Nishino K, Kumagai T, Okuyama T, Okami J, Higashiyama M, Kodama K, Imamura F, Kato K, Clin Cancer Res 2011 17 7808 7815 10.1158/1078-0432.CCR-11-1712 21976538
33. A noninvasive system for monitoring resistance to epidermal growth factor receptor tyrosine kinase inhibitors with plasma DNA. Nakamura T, Sueoka-Aragane N, Iwanaga K, Sato A, Komiya K, Abe T, Ureshino N, Hayashi S, Hosomi T, Hirai M, Sueoka E, Kimura S, J Thorac Oncol 2011 6 1639 1648 10.1097/JTO. 0b013e31822956e8 21921847
34. Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer. Kim HJ, Lee KY, Kim YC, Kim KS, Lee SY, Jang TW, Lee MK, Shin KC, Lee GH, Lee JC, Lee JE, Kim SY, Lung Cancer 2011 75 321 325 21930325
35. Detection of EGFR mutation status in lung adenocarcinoma specimens with different proportions of tumor cells using two methods of differential sensitivity. Han HS, Lim SN, An JY, Lee KM, Choe KH, Lee KH, Kim ST, Son SM, Choi SY, Lee HC, Lee OJ, J Thorac Oncol 2012 7 355 364 10.1097/JTO. 0b013e31823c4c1b 22157369